SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
Innovent will supply sintilimab for the collaborated clinical trial
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
Phase 3 data expected in the second half of 2024
The collaboration brings a seamless digital experience to more formulators worldwide
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Subscribe To Our Newsletter & Stay Updated
